Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jul 22, 2009

Polish University to Use Cellectricon’s Transfection System

  • The University of Lodz, Poland, will invest in Cellectricon’s Cellaxess®HT. The university plans to use the product for its research program focusing on cell biology and molecular genetics of clinically relevant genes related to cancer treatment.

    Cellaxess®HT is a fully automated workstation for high-throughput transfection. The system enables reagent-free delivery of siRNA and cDNA to a range of primary cells and cell lines.



Related content

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »